20 May 2013
Keywords: pfizer, expands, patient, access, maraviroc, world, drug
Article | 11 December 2006
World drug giant Pfizer plans to establish a multi-national Expanded Access Program to make its investigational CCR5 antagonist maraviroc
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
11 December 2006
© 2013 thepharmaletter.com